Irradiation Enhances the Malignancy-promoting Behaviors of Cancer-associated Fibroblasts

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Nov 7

PMID 36338684

Authors

Ziyue Zhang

Yi Dong

Bin Wu

Yingge Li

Zehui Liu

Zheming Liu

Yanjun Gao

Likun Gao

Qibin Song

Zhongliang Zheng

Yi Yao

Affiliations

Soon will be listed here.

Abstract

Background: Cancer-associated fibroblasts (CAFs) are the important component of the tumor microenvironment (TME). Previous studies have found that some pro-malignant CAFs participate in the resistance to radiotherapy as well as the initiation and progression of tumor recurrence. However, the exact mechanism of how radiation affects CAFs remains unclear. This study aimed to explore the effect and possible mechanism of radiation-activated CAFs, and its influence on lung cancer.

Methods: CAFs were isolated from surgical specimens and irradiated with 8Gy x-rays. The changes in cell morphology and subcellular structure were observed. CAFs marker proteins such as FAP and α-SMA were detected by Western Blotting. Cell counting kit-8 (CCK8) assay, flow cytometry, wound healing assay, and transwell chamber assay was used to detect the activation of cell viability and migration ability. A nude mouse xenograft model was established to observe the tumorigenicity of irradiated CAFs . The genomic changes of CAFs after radiation activation were analyzed by transcriptome sequencing technology, and the possible mechanisms were analyzed.

Results: The CAFs showed a disorderly growth pattern after X-ray irradiation. Subcellular observations suggested that metabolism-related organelles exhibited more activity. The expression level of CAFs-related signature molecules was also increased. The CAFs irradiated by 8Gy had good proliferative activity. In the (indirect) co-culture system, CAFs showed radiation protection and migration induction to lung cancer cell lines, and this influence was more obvious in radiation-activated CAFs. The radiation protection was decreased after exosome inhibitors were applied. Vivo study also showed that radiation-activated CAFs have stronger tumorigenesis. Transcriptome analysis showed that genes were enriched in several pro-cancer signaling pathways in radiation-activated CAFs.

Conclusions: Our study confirmed that CAFs could be activated by ionizing radiation. Irradiation-activated CAFs could promote cancer cell proliferation, migration, radiotherapy tolerance, and tumorigenesis. These results suggested that irradiation-activated CAFs might participate in the recurrence of lung cancer after radiotherapy, and the inhibition of CAFs activation may be an important way to improve clinical radiotherapy efficacy.

Citing Articles

Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy.

Metzger G, Bayerl C, Rogasch J, Furth C, Wetz C, Beck M Theranostics. 2024; 14(11):4184-4197.

PMID: 39113796 PMC: 11303068. DOI: 10.7150/thno.95329.

Studies on Human Cultured Fibroblasts and Cutaneous Squamous Cell Carcinomas Suggest That Overexpression of Histone Variant H2A.J Promotes Radioresistance and Oncogenic Transformation.

Freyter B, Abd Al-Razaq M, Hecht M, Rube C, Rube C Genes (Basel). 2024; 15(7).

PMID: 39062630 PMC: 11275829. DOI: 10.3390/genes15070851.

A bibliometric and visual analysis of cancer-associated fibroblasts.

Yuan W, Zhang J, Chen H, Yuan Y, Zhuang Y, Zhou H Front Immunol. 2024; 14:1323115.

PMID: 38173726 PMC: 10762783. DOI: 10.3389/fimmu.2023.1323115.

References

McLaughlin M, Patin E, Pedersen M, Wilkins A, Dillon M, Melcher A . Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Cancer. 2020; 20(4):203-217. DOI: 10.1038/s41568-020-0246-1. View

Kaps L, Schuppan D . Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers. Cells. 2020; 9(9). PMC: 7563527. DOI: 10.3390/cells9092027. View

Sato A, Rahman N, Shimizu A, Ogita H . Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment. Cancer Sci. 2021; 112(10):4005-4012. PMC: 8486192. DOI: 10.1111/cas.15114. View

Kim C, Kim J, Nam S, Yang K, Jeong M, Kim H . Low-dose of ionizing radiation enhances cell proliferation via transient ERK1/2 and p38 activation in normal human lung fibroblasts. J Radiat Res. 2007; 48(5):407-15. DOI: 10.1269/jrr.07032. View

Su S, Chen J, Yao H, Liu J, Yu S, Lao L . CD10GPR77 Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018; 172(4):841-856.e16. DOI: 10.1016/j.cell.2018.01.009. View

Verset L, Tommelein J, Moles Lopez X, Decaestecker C, Boterberg T, De Vlieghere E . Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer. Radiother Oncol. 2015; 116(3):449-54. DOI: 10.1016/j.radonc.2015.05.007. View

Liu L, Zhang Z, Zhou L, Hu L, Yin C, Qing D . Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype. Exp Cell Res. 2020; 391(2):111956. DOI: 10.1016/j.yexcr.2020.111956. View

Fiori M, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R . Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019; 18(1):70. PMC: 6441236. DOI: 10.1186/s12943-019-0994-2. View

Dumont N, Liu B, DeFilippis R, Chang H, Rabban J, Karnezis A . Breast fibroblasts modulate early dissemination, tumorigenesis, and metastasis through alteration of extracellular matrix characteristics. Neoplasia. 2013; 15(3):249-62. PMC: 3593149. DOI: 10.1593/neo.121950. View

10.

Tommelein J, De Vlieghere E, Verset L, Melsens E, Leenders J, Descamps B . Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation. Cancer Res. 2017; 78(3):659-670. DOI: 10.1158/0008-5472.CAN-17-0524. View

11.

Kalluri R . The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016; 16(9):582-98. DOI: 10.1038/nrc.2016.73. View

12.

Fitzgerald A, Weiner L . The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020; 39(3):783-803. PMC: 7487063. DOI: 10.1007/s10555-020-09909-3. View

13.

Barker H, Paget J, Khan A, Harrington K . The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015; 15(7):409-25. PMC: 4896389. DOI: 10.1038/nrc3958. View

14.

Chen J, Zhou R, Liang Y, Fu X, Wang D, Wang C . Blockade of lncRNA-ASLNCS5088-enriched exosome generation in M2 macrophages by GW4869 dampens the effect of M2 macrophages on orchestrating fibroblast activation. FASEB J. 2019; 33(11):12200-12212. PMC: 6902732. DOI: 10.1096/fj.201901610. View

15.

Dinkins M, Dasgupta S, Wang G, Zhu G, Bieberich E . Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2014; 35(8):1792-800. PMC: 4035236. DOI: 10.1016/j.neurobiolaging.2014.02.012. View

16.

Xia W, Feng W, Zhang C, Shen Y, Zhang Q, Yu W . Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge-a narrative review. Transl Lung Cancer Res. 2020; 9(5):2120-2136. PMC: 7653139. DOI: 10.21037/tlcr-20-827. View

17.

Richards K, Zeleniak A, Fishel M, Wu J, Littlepage L, Hill R . Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene. 2016; 36(13):1770-1778. PMC: 5366272. DOI: 10.1038/onc.2016.353. View

18.

Hoffman D, Dragojevic I, Hoisak J, Hoopes D, Manger R . Lung Stereotactic Body Radiation Therapy (SBRT) dose gradient and PTV volume: a retrospective multi-center analysis. Radiat Oncol. 2019; 14(1):162. PMC: 6724320. DOI: 10.1186/s13014-019-1334-9. View

19.

Shi L, Zhu W, Huang Y, Zhuo L, Wang S, Chen S . Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer. Clin Transl Med. 2022; 12(7):e989. PMC: 9299573. DOI: 10.1002/ctm2.989. View

20.

Donlon N, Power R, Hayes C, Reynolds J, Lysaght J . Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity. Cancer Lett. 2021; 502:84-96. DOI: 10.1016/j.canlet.2020.12.045. View